Latest California Healthline Stories
Despite the Hoopla, Vaccines Should Be in Reach This Cough-and-Cold Season
Recommendations surrounding covid vaccinations and other such shots have been confusing. Ultimately, though, little has changed. Here’s what you need to know.
KFF Health News' 'What the Health?': Schrödinger’s Government Shutdown
Democrats and Republicans remain stalled over funding the federal government as Republicans launch a new attack on the Affordable Care Act. Meanwhile, the Trump administration is taking advantage of the shutdown to lay off workers from programs supported mostly by Democrats. Anna Edney of Bloomberg News, Lauren Weber of The Washington Post, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews health insurance analyst Louise Norris about Medicare open enrollment.
It’s a Bird! It’s a Plane! It’s a Chemtrail? New Conspiracy Theory Takes Wing at Kennedy’s HHS
The idea that airplane vapors are toxic to people or that there are ongoing efforts to intentionally change the climate made the social media rounds. Now, it has found advocates at the Department of Health and Human Services.
RFK Jr. Misses Mark in Touting Rural Health Transformation Fund as Historic Infusion of Cash
The health secretary’s statement doesn’t consider the impact that the Medicaid cuts advanced in the same law will have on health care in rural America.
KFF Health News' 'What the Health?': Starting To Feel the Shutdown’s Bite
The government shutdown continues with no end in sight, and while it theoretically should not affect entitlement programs, the lapse of some related authorizations — like for Medicare telehealth programs — is leaving some doctors and patients high and dry. Meanwhile, the FDA quietly approved a new generic abortion pill. Sarah Karlin-Smith of Pink Sheet, Tami Luhby of CNN, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss those stories and more. Also, Rovner interviews Sarah Grusin of the National Health Law Program.
Inside the High-Stakes Battle Over Vaccine Injury Compensation, Autism, and Public Trust
The evidence is unequivocal: Vaccines do not cause autism. Yet adding autism to the list of conditions covered by a federal payout program, as health secretary Robert F. Kennedy Jr. seems inclined to do, could threaten its financial viability. Such a move also would suggest that the science is unsettled, that vaccines may be riskier than diseases, which is a fallacy.
In Hepatitis B Vaccine Debate, CDC Panel Sidesteps Key Exposure Risk
At a recent meeting of a key vaccine advisory panel, members debated changes to the timing of hepatitis B vaccination, while largely ignoring the risk of early childhood transmission from day care or household contact. A few days later, President Donald Trump did the same.
Off-Label Drug Helps One Boy With Autism Speak, Parents Say. But Experts Want More Data.
This week, the FDA began the process of approving leucovorin, an inexpensive, generic drug derived from folic acid, to help children diagnosed with autism.
In a rambling news conference that shocked public health experts, President Donald Trump — without scientific evidence — blamed the over-the-counter drug acetaminophen, and too many childhood vaccines, for the increase in autism diagnoses in the U.S. That came days after a key immunization advisory panel, newly reconstituted with vaccine doubters, changed several long-standing recommendations. Former Centers for Disease Control and Prevention official Demetre Daskalakis joins KFF Health News’ Julie Rovner to discuss those stories. Meanwhile, Sandhya Raman of CQ Roll Call and Anna Edney of Bloomberg News join Rovner with the rest of the news, including a threat by the Trump administration to fire rather than furlough federal workers if Congress fails to fund the government beyond the Oct. 1 start of the new fiscal year.
Amid Confusion Over US Vaccine Recommendations, States Try to ‘Restore Trust’
The decisions by the Advisory Committee on Immunization Practices matter, because insurers and federal programs rely on them, but they are not binding. States can follow the recommendations, or not.